Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease-Reference-Cited by-同舟云学术

Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease

Published:2022-02 Issue:2 Volume:135 Page:235-243.e2
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Yoder Lindsay^ORCID,Mladenovic Andrea,Pike Francis,Vuppalanchi Raj^ORCID,Hanson Haleigh,Corbito Laura,Desai Archita P.^ORCID,Chalasani Naga,Orman Eric S.^ORCID

Funder

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Hospital readmissions in patients with cirrhosis: a systematic review;Orman;J Hosp Med,2018

2. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States;Shaheen;Liver Int,2019

3. Readmission rates and associated outcomes for alcoholic hepatitis: a nationwide cohort study;Adejumo;Dig Dis Sci,2020

4. Incidence and risk factors associated with 30-day readmission for alcoholic hepatitis;Garg;J Clin Gastroenterol,2019

5. Alcohol rehabilitation within 30 days of hospital discharge is associated with reduced readmission, relapse, and death in patients with alcoholic hepatitis;Peeraphatdit;Clin Gastroenterol Hepatol,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Evaluation of Emergency Department Utilization by Patients With Cirrhosis;American Journal of Gastroenterology;2024-06-24

2. Preventing Readmissions of Hepatic Encephalopathy;Clinics in Liver Disease;2024-05

3. Clinical characteristics and prognosis of hospitalized patients with moderate alcohol‐associated hepatitis;Liver International;2023-10-30

4. Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis;American Journal of Gastroenterology;2023-09-27

5. Barriers to surveillance for hepatocellular cancer among patients with chronic liver disease -providers' perspectives;Hepatoma Research;2023